Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $6.14B | +$208M | 81 | 0.15% | Increased |
|
| 2 |
BlackRock
New York
| $6.14B | +$412M | 89 | 0.17% | Increased |
|
| 3 |
Fidelity Investments
Boston,
Massachusetts
| $3.51B | +$213M | 68 | 0.29% | Increased |
|
| 4 |
State Street
Boston,
Massachusetts
| $2.79B | -$74.8M | 82 | 0.15% | Reduced |
|
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
| $2.08B | +$378M | 44 | 0.29% | Increased |
|
| 6 |
Janus Henderson Group
London,
| $1.95B | -$34.3M | 27 | 1.21% | Reduced |
|
| 7 |
Wellington Management Group
Boston,
Massachusetts
| $1.89B | +$94.6M | 18 | 0.36% | Increased |
|
| 8 |
Morgan Stanley
New York
| $1.71B | +$192M | 93 | 0.17% | Increased |
|
| 9 |
Dodge & Cox
San Francisco,
California
| $1.66B | -$391M | 1 | 1.1% | Reduced |
|
| 10 |
Primecap Management
Pasadena,
California
| $1.64B | -$143M | 5 | 1.37% | Reduced |
|
| 11 |
Geode Capital Management
Boston,
Massachusetts
| $1.18B | +$28.1M | 92 | 0.14% | Increased |
|
| 12 |
Avoro Capital Advisors
New York
| $1.18B | +$253M | 4 | 16.03% | Increased |
|
| 13 |
Dimensional Fund Advisors
Austin,
Texas
| $1.11B | +$18.4M | 52 | 0.35% | Increased |
|
| 14 |
Franklin Resources
San Mateo,
California
| $1.11B | -$175M | 34 | 0.53% | Reduced |
|
| 15 |
JP Morgan Chase
New York
| $1.1B | +$48.9M | 74 | 0.12% | Increased |
|
| 16 |
RTW Investments
New York
| $1.04B | +$59.5M | 6 | 19.78% | Increased |
|
| 17 |
Bank of America
Charlotte,
North Carolina
| $1.03B | -$327M | 81 | 0.11% | Reduced |
|
| 18 |
Goldman Sachs
New York
| $1.02B | -$24.9M | 64 | 0.22% | Reduced |
|
| 19 |
Charles Schwab
San Francisco,
California
| $904M | +$18.3M | 53 | 0.26% | Increased |
|
| 20 |
Capital World Investors
Los Angeles,
California
| $873M | +$121M | 5 | 0.17% | Increased |
|
| 21 |
T. Rowe Price Investment Management
Baltimore,
Maryland
| $851M | +$79.6M | 7 | 0.58% | Increased |
|
| 22 |
ARK Investment Management
St. Petersburg,
Florida
| $837M | -$42.3M | 4 | 5.54% | Reduced |
|
| 23 |
Loomis, Sayles & Company
Boston,
Massachusetts
| $791M | -$54.1M | 7 | 1.28% | Reduced |
|
| 24 |
Northern Trust
Chicago,
Illinois
| $788M | -$4.28M | 78 | 0.15% | Reduced |
|
| 25 |
EC
EcoR1 Capital
San Francisco,
California
| $755M | +$135M | 9 | 18.49% | Increased |
|